Discover Stelo's top-performing Facebook ads. Analyze creatives, messaging, and campaign performance.
Get unlimited access to analyze competitor ads, save creatives, and discover winning strategies.
See all ads on AdLibrary →Stelo is Dexcom's OTC continuous glucose monitor brand, launched in summer 2024 as the first FDA-cleared CGM available over the counter for non-insulin-dependent users. Built on Dexcom's clinical CGM platform, Stelo targets wellness-oriented adults without diabetes who want to understand how food, exercise, and lifestyle affect their glucose levels.
